San Diego-centered Viking Therapeutics marked by itself as a significant competitor inside the weight loss drug market in February after revealing promising info from a mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given to be a weekly injection and in March the company unveiled d